# Efficacy and Safety of Sipjeondaebo-tang on Korean Patients With Cold Hypersensitivity in the Hands and Feet (SDT)

> **NCT03374345** · PHASE2,PHASE3 · COMPLETED · sponsor: **Gachon University Gil Oriental Medical Hospital** · enrollment: 60 (actual)

## Conditions studied

- Cold Hypersensitivity

## Interventions

- **DRUG:** Sipjeondaebo-tang Granule
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03374345
- **Lead sponsor:** Gachon University Gil Oriental Medical Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-31
- **Primary completion:** 2019-12-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-09-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03374345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03374345, "Efficacy and Safety of Sipjeondaebo-tang on Korean Patients With Cold Hypersensitivity in the Hands and Feet (SDT)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03374345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*